Beyond the ISCHEMIA Trial: Revascularization for Stable Ischemic Heart Disease in Patients With High‐Risk Coronary Anatomical Features by Brian A. Bergmark, David A. Morrow

Get full text

Biomarker of Collagen Turnover (C‐Terminal Telopeptide) and Prognosis in Patients With Non‐ST‐Elevation Acute Coronary Syndromes by Thomas A. Zelniker, Petr Jarolim, Benjamin M. Scirica, Eugene Braunwald, Jeong‐Gun Park, Saumya Das, Marc S. Sabatine, David A. Morrow

Get full text

Serial Assessment of Shock Severity in Cardiac Intensive Care Unit Patients by Jacob C. Jentzer, Sean Van Diepen, Parag C. Patel, Timothy D. Henry, David A. Morrow, David A. Baran, Kianoush B. Kashani

Get full text

Cardiovascular Biomarkers and Heart Failure Risk in Stable Patients With Atherothrombotic Disease: A Nested Biomarker Study From TRA 2°P‐TIMI 50 by David D. Berg, Benjamin L. Freedman, Marc P. Bonaca, Petr Jarolim, Benjamin M. Scirica, Erica L. Goodrich, Marc S. Sabatine, David A. Morrow

Get full text

Care Setting Intensity and Outcomes After Emergency Department Presentation Among Patients With Acute Heart Failure by Livia Goldraich, Peter C. Austin, Limei Zhou, Jack V. Tu, Michael J. Schull, Susanna Mak, Heather J. Ross, David A. Morrow, Douglas S. Lee

Get full text

Multimarker Risk Stratification in Patients With Acute Myocardial Infarction by Michelle L. O'Donoghue, David A. Morrow, Christopher P. Cannon, Petr Jarolim, Nihar R. Desai, Matthew W. Sherwood, Sabina A. Murphy, Robert E. Gerszten, Marc S. Sabatine

Get full text

Derivation and Validation of a Novel Cardiac Intensive Care Unit Admission Risk Score for Mortality by Jacob C. Jentzer, Nandan S. Anavekar, Courtney Bennett, Dennis H. Murphree, Mark T. Keegan, Brandon Wiley, David A. Morrow, Joseph G. Murphy, Malcolm R. Bell, Gregory W. Barsness

Get full text

Interleukin‐6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID‐TIMI 52 (Stabilization of Plaque Using Darapladib—Thromboly... by Christina L. Fanola, David A. Morrow, Christopher P. Cannon, Petr Jarolim, Mary Ann Lukas, Christoph Bode, Judith S. Hochman, Erica L. Goodrich, Eugene Braunwald, Michelle L. O'Donoghue

Get full text

Percutaneous right ventricular assist device–supported ventricular tachycardia ablation in a patient with severe right ventricular dysfunction by Martin Aguilar, MD, PhD, Allison L. Tsao, MD, Kevin J. Croce, MD, PhD, William Sauer, MD, FHRS, David A. Morrow, MD, MPH, Usha B. Tedrow, MD, MSc, FHRS

Get full text

Role of Critical Care Medicine Training in the Cardiovascular Intensive Care Unit: Survey Responses From Dual Certified Critical Care Cardiologists by Samuel B. Brusca, Christopher Barnett, Brendan J. Barnhart, Weifeng Weng, David A. Morrow, Jeffrey S. Soble, Jason N. Katz, Brandon M. Wiley, Sean van Diepen, Antonio D. Gomez, Michael A. Solomon

Get full text

Epidemiology and Management of ST‐Segment–Elevation Myocardial Infarction in Patients With COVID‐19: A Report From the American Heart Association COVID‐19 Cardiovascular Disease Re... by Ankeet S. Bhatt, Anubodh S. Varshney, Erica L. Goodrich, Jingyi Gong, Curtis Ginder, Balimkiz C. Senman, Matthew Johnson, Kayleigh Butler, Ann E. Woolley, James A. de Lemos, David A. Morrow, Erin A. Bohula

Get full text

Gut Microbiota‐Dependent Trimethylamine N‐oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS‐TIMI 54 Trial... by Baris Gencer, Xinmin S. Li, Yared Gurmu, Marc P. Bonaca, David A. Morrow, Marc Cohen, Deepak L. Bhatt, P. Gabriel Steg, Robert F. Storey, Per Johanson, Zeneng Wang, Stanley L. Hazen, Marc S. Sabatine

Get full text

N‐Terminal Pro‐B‐Type Natriuretic Peptide as a Biomarker for the Severity and Outcomes With COVID‐19 in a Nationwide Hospitalized Cohort by Christian O’Donnell, Melanie D. Ashland, Elena C. Vasti, Ying Lu, Andrew Y. Chang, Paul Wang, Lori B. Daniels, James A. de Lemos, David A. Morrow, Fatima Rodriguez, Connor G. O’Brien

Get full text

Site-level variability in the processes of care and outcomes over time among patients with COVID-19 and myocardial injury: Insights from the American Heart Association's COVID-19 C... by Yasser M. Sammour, John A. Spertus, Kevin Kennedy, David A. Morrow, Lori B. Daniels, Phil Jones, Heather Alger, Laura Stevens, Alpesh Shah, Sachin S. Goel, James A. de Lemos, Salim S. Hayek, Nadia R. Sutton, Neal S. Kleiman

Get full text

Ranolazine in Symptomatic Diabetic Patients Without Obstructive Coronary Artery Disease: Impact on Microvascular and Diastolic Function by Nishant R. Shah, Michael K. Cheezum, Vikas Veeranna, Stephen J. Horgan, Viviany R. Taqueti, Venkatesh L. Murthy, Courtney Foster, Jon Hainer, Karla M. Daniels, Jose Rivero, Amil M. Shah, Peter H. Stone, David A. Morrow, Michael L. Steigner, Sharmila Dorbala, Ron Blankstein, Marcelo F. Di Carli

Get full text

Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS–TIMI 54 by Marc P. Bonaca, Stephen D. Wiviott, David A. Morrow, P. Gabriel Steg, Christian Hamm, Deepak L. Bhatt, Robert F. Storey, Marc Cohen, Julia Kuder, KyungAh Im, Giulia Magnani, Andrzej Budaj, José C. Nicolau, Alexander Parkhomenko, José López‐Sendón, Mikael Dellborg, Rafael Diaz, Frans Van de Werf, Ramón Corbalán, Assen Goudev, Eva C. Jensen, Per Johanson, Eugene Braunwald, Marc S. Sabatine

Get full text